Skip to main content
. 2017 Jul 6;5(7):E653–E662. doi: 10.1055/s-0043-110050

Table 2. Incidence ratio of postoperative bleeding according to antithrombotic treatment in patients receiving antithrombotic therapy (group A).

Number of procedures, n Incidence of postoperative bleeding, n (% of incidence ratio)
Antithrombotic agent 108 12 (11.1)
Single antiplatelet agent  72  3 (4.2)

  • Aspirin

  35  2 (5.7)

  • Thienopyridine

  10  0 (0.0)

  • Other antiplatelet agent

  27  1 (3.7)
Single anticoagulant  14  3 (21.4)

  • Warfarin

  14  3 (21.4)
Dual antiplatelet therapy  16  5 (31.3)

  • Aspirin + thienopyridine

   5  4 (80.0)

  • Aspirin + other antiplatelet agent

   9  1 (11.1)

  • Thienopyridine + other antiplatelet agent

   2  0 (0.0)
Antiplatelet agent and anticoagulant   6  1 (16.6)

  • Warfarin + aspirin

   2  1 (50.0)

  • Warfarin + other antiplatelet agent

   3  0 (0.0)

  • Dabigatran + other antiplatelet agent

   1  0 (0.0)